Search Results - "BETHELL, Richard"

Refine Results
  1. 1

    Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease by WHITE, Peter W, LLINAS-BRUNET, Montse, KUKOLJ, George, AMAD, Ma'an, BETHELL, Richard C, BOLGER, Gordon, CORDINGLEY, Michael G, JIANMIN DUAN, GARNEAU, Michel, LAGACE, Lisette, THIBEAULT, Diane

    Published in Antimicrobial Agents and Chemotherapy (01-11-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication by Vaillancourt, Frédéric H, Pilote, Louise, Cartier, Mireille, Lippens, Julie, Liuzzi, Michel, Bethell, Richard C, Cordingley, Michael G, Kukolj, George

    Published in Virology (New York, N.Y.) (25-04-2009)
    “…Abstract A functional screen of an adenovirus-delivered shRNA library that targets ∼ 4500 host genes was performed to identify cellular factors that regulate…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    CD160 isoforms and regulation of CD4 and CD8 T-cell responses by El-Far, Mohamed, Pellerin, Charles, Pilote, Louise, Fortin, Jean-Francois, Lessard, Ivan A D, Peretz, Yoav, Wardrop, Elizabeth, Salois, Patrick, Bethell, Richard C, Cordingley, Michael G, Kukolj, George

    Published in Journal of translational medicine (02-09-2014)
    “…Coexpression of CD160 and PD-1 on HIV-specific CD8+ T-cells defines a highly exhausted T-cell subset. CD160 binds to Herpes Virus Entry Mediator (HVEM) and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Evidence for Zanamivir Resistance in an Immunocompromised Child Infected with Influenza B Virus by Gubareva, Larisa V., Matrosovich, Mikhail N., Brenner, Malcolm K., Bethell, Richard C., Webster, Robert G.

    Published in The Journal of infectious diseases (01-11-1998)
    “…Zanamivir, a neuraminidase inhibitor, has shown promise as a drug to control influenza. During prolonged treatment with zanamivir, a mutant virus was isolated…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data by Rioux, Nathalie, Batonga, Joëlle, Colombo, Federico, Massé, Jonathan, Zouki, Christine, Ribadeneira, Maria D., Duan, Jianmin, Bethell, Richard C.

    Published in Xenobiotica (01-07-2013)
    “…Abstract 1. The present study evaluates which factors should be incorporated into a simplified approach to reasonably predict CYP3A-mediated drug-drug…”
    Get full text
    Journal Article
  16. 16

    Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients by CAHN, Pedro, CASSETTI, Isabel, WOOD, Robin, PHANUPHAK, Praphan, SHIVELEY, Leeann, BETHELL, Richard C, SAWYER, James

    Published in AIDS (London) (12-06-2006)
    “…Apricitabine (formerly AVX754 and SPD754) is a deoxycytidine analogue nucleoside reverse transcriptase inhibitor in clinical development for patients with HIV…”
    Get full text
    Journal Article
  17. 17

    Characterization of Influenza A/HongKong/156/97 (H5N1) Virus in a Mouse Model and Protective Effect of Zanamivir on H5N1 Infection in Mice by Gubareva, Larisa V., McCullers, Jonathan A., Bethell, Richard C., Webster, Robert G.

    Published in The Journal of infectious diseases (01-12-1998)
    “…A recent outbreak of influenza in Hong Kong was caused by a highly virulent virus of avian origin. Concern that the appearance of such a virus in the human…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20